BMO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BMO is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The business is fundamentally healthy and the latest quarter was strong, but the stock is already near resistance, options sentiment is cautious, and there is no Intellectia buy signal today. My direct view: wait for a better entry rather than buying immediately.
The trend is constructive but not ideal for an immediate entry. MACD histogram is positive at 0.669, showing bullish momentum, and the moving averages are stacked bullishly (SMA_5 > SMA_20 > SMA_200), which supports an uptrend. However, RSI_6 at 73.655 suggests the stock is extended rather than attractively priced. Price at 161.84 is sitting just below resistance at R1 162.218 and above the pivot at 157.221, so upside from here looks limited in the very near term. The short-term pattern data also points to weak near-term returns.
["Q2 results were strong, with adjusted EPS growing 40% year over year to $3.67.", "Record net income of $2.7 billion and adjusted net income up 34% year over year.", "Strong capital ratio of 13% supports financial stability and shareholder returns.", "Dividend increased to CAD 1.71 per share, signaling confidence in earnings power.", "Several analysts raised price targets after the Q2 report.", "Congress trading shows 1 purchase and 0 sales in the last 90 days, indicating positive institutional-like political sentiment."]
["No AI Stock Picker signal today and no recent SwingMax buy signal.", "BMO is trading close to resistance, limiting immediate upside.", "RSI is elevated, so the stock looks somewhat extended.", "Open interest put-call ratio of 1.89 suggests hedging or downside caution.", "Barclays remains Underweight and BofA remains Neutral, showing Wall Street is not uniformly bullish.", "Short-term pattern analysis suggests potential weakness over the next month."]
Latest quarter: Q2. Financial performance was strong, with adjusted EPS up 40% year over year to $3.67, adjusted net income up 34% year over year to C$9.57 billion, and record net income of $2.7 billion. The 13% capital ratio is healthy and the dividend increase reinforces balance-sheet strength and shareholder returns. Growth trends are positive, especially earnings and profitability.
Analyst sentiment is mixed but improving after earnings. Multiple firms raised price targets on 2026-05-28, including Desjardins, CIBC, BofA, TD Securities, RBC, and Barclays, which shows estimates were reset higher after Q2 results. However, the rating stance is still divided: some are bullish or outperform, while others remain neutral, hold, sector perform, or underweight. Wall Street’s pros point to stronger-than-expected Q2 results, operating leverage, and improving credit trends; the cons focus on valuation, lingering caution on the U.S. segment, and limited upside at current levels.
